首页> 外文期刊>Medical Science Monitor Basic Research >Concurrent Left Ventricular Assist Device (LVAD) Implantation and Percutaneous Temporary RVAD Support via CardiacAssist Protek-Duo TandemHeart to Preempt Right Heart Failure
【24h】

Concurrent Left Ventricular Assist Device (LVAD) Implantation and Percutaneous Temporary RVAD Support via CardiacAssist Protek-Duo TandemHeart to Preempt Right Heart Failure

机译:通过CardiacAssist Protek-Duo TandemHeart同时进行左心室辅助装置(LVAD)植入和经皮RVAD临时支持,以预防右心衰竭

获取原文
           

摘要

Right ventricular failure (RVF) is an unfortunate complication that continues to limit outcomes following durable left ventricular assist device (LVAD) implantation. Despite several ‘RVF risk scores’ having been proposed, preoperative prediction of post-LVAD RVF remains a guesstimate at best. Current strategies for institution of temporary RVAD support are invasive, necessitate additional re-thoracotomy, restrict postoperative mobilization, and/or entail prolonged retention of prosthetic material in-situ . The authors propose a novel surgical strategy comprising simultaneous implantation of a permanent LVAD and percutaneous TandemHeart~(?)plus ProtekDuo~(?)to provide temporary RVAD support and preempt RVF in patients with impaired RV function.
机译:右心室衰竭(RVF)是一种不幸的并发症,在持久性左心室辅助装置(LVAD)植入后继续限制结局。尽管已经提出了多个“ RVF风险评分”,但LVAD术后RVF的术前预测充其量仍是推测。当前用于临时RVAD支持的策略是侵入性的,需要进行额外的开胸手术,限制术后动员和/或需要在原位长时间保留修复材料。作者提出了一种新颖的手术策略,包括同时植入永久性LVAD和经皮TandemHeart(?)加上ProtekDuo(?),以为RV功能受损的患者提供临时RVAD支持并抢占RVF。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号